Core Viewpoint - The company Gan Cao Doctor, an online TCM diagnosis platform, has submitted its listing application to the Hong Kong Stock Exchange, with a valuation of 1.6 billion yuan in its latest financing round, benefiting from AI-assisted TCM diagnosis and the "Internet + TCM" trend [1] Group 1: Company Overview - Gan Cao Doctor is positioned as the largest online TCM comprehensive service provider in China, holding a 4.9% market share [1] - The company reported revenues of 600 million yuan, 690 million yuan, and 550 million yuan for the first three quarters of 2023, 2024, and 2025 respectively [1] - The net profit is expected to reach 10 million yuan in 2024, but the company anticipates a loss in the first three quarters of 2025 [1] Group 2: Operational Challenges - The company acknowledges that its operating performance is directly affected by sales costs, with fluctuations in procurement prices, supply chain disruptions, and seasonal variations in TCM materials potentially impacting unit costs [1] - There are concerns regarding the quality of registered physicians on the platform, as many do not have detailed qualifications, and some claim to specialize in a wide range of conditions without sufficient verification [2] - The platform's regulatory measures and compliance are questioned, with reports of potential kickbacks for physicians, which contradicts national regulations on medical practices [3]

Core Viewpoint - The development of traditional Chinese medicine (TCM) in Xinjiang has undergone significant transformation over the past 70 years, showcasing remarkable achievements and advancements in medical practices and integration with local ethnic medicine [1][8]. Group 1: Historical Development - Xinjiang's TCM has evolved from basic medical facilities to a regional treatment center, with the establishment of independent departments and significant growth in medical staff and resources [2][4]. - The Xinjiang Traditional Chinese Medicine Hospital's dermatology department has expanded from 3 medical staff to 43, and from no dedicated beds to 90 beds over 23 years, becoming a national clinical key specialty [2][4]. Group 2: Innovations and Achievements - The hospital has developed innovative external treatment techniques for skin diseases, resulting in 4 national invention patents and 28 utility model patents [2][4]. - TCM external treatment techniques have been incorporated into national treatment plans for advantageous diseases, enhancing the academic influence of Xinjiang's TCM across the country [4][8]. Group 3: Integration and Accessibility - The integration of TCM with local ethnic medicine, such as Uyghur and Kazakh medicine, has played a crucial role in addressing the health needs of diverse populations in Xinjiang [8]. - The use of new media and internet technology has enabled widespread dissemination of TCM knowledge, allowing thousands of grassroots doctors and patients to access new treatment techniques without geographical limitations [5][7]. Group 4: Future Prospects - The future of TCM in Xinjiang is expected to focus on personalized treatment plans, utilizing modern scientific techniques to validate TCM efficacy and develop tailored strategies for the multi-ethnic population [8]. - The implementation of the "Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Regulations" in May 2024 is anticipated to enhance the regulation of TCM resources, talent cultivation, and service capabilities [8].